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Abstract: Mechanisms for somatic chromosomal mosaicism (SCM) and chromosomal instability
(CIN) are not completely understood. During molecular karyotyping and bioinformatic analyses of
children with neurodevelopmental disorders and congenital malformations (n = 612), we observed
colocalization of regular chromosomal imbalances or copy number variations (CNV) with mosaic
ones (n = 47 or 7.7%). Analyzing molecular karyotyping data and pathways affected by CNV burdens,
we proposed a mechanism for SCM/CIN, which had been designated as “chromohelkosis” (from the
Greek words chromosome ulceration/open wound). Briefly, structural chromosomal imbalances are
likely to cause local instability (“wreckage”) at the breakpoints, which results either in partial/whole
chromosome loss (e.g., aneuploidy) or elongation of duplicated regions. Accordingly, a function
for classical/alpha satellite DNA (protection from the wreckage towards the centromere) has been
hypothesized. Since SCM and CIN are ubiquitously involved in development, homeostasis and
disease (e.g., prenatal development, cancer, brain diseases, aging), we have metaphorically (ironically)
designate the system explaining chromohelkosis contribution to SCM/CIN as the cytogenomic “theory
of everything”, similar to the homonymous theory in physics inasmuch as it might explain numerous
phenomena in chromosome biology. Recognizing possible empirical and theoretical weaknesses of
this “theory”, we nevertheless believe that studies of chromohelkosis-like processes are required to
understand structural variability and flexibility of the genome.
Keywords: chromosome; copy number variations; chromosome instability; chromosomal mosaicism;
chromosomal imbalances; aneuploidy; disease; aging; pathways; cytogenomics
1. Introduction
Despite the fact that mechanisms of chromosomal instability (CIN) and somatic chromosomal
mosaicism (SCM) remain to be further explored [1–3], CIN-associated genome behavior (chromothripsis,
chromoanasynthesis, chromoanagenesis) has already been described [4–6]. Uncovering underlying
processes of the commonest types of SCM/CIN (e.g., aneuploidy) is generally less successful [7–9]. Still,
somatic aneuploidy (CIN manifested as aneuploidy) has been found to result from alterations to a number
of molecular/cellular pathways, gene mutations [10,11], and/or genetic–environmental interactions [12].
In the postgenomic context, it appears important to evaluate the contribution of heritable/sporadic
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cytogenomic variations (i.e., genomic variations at chromosomal and subchromosomal levels) to the
formation of CIN and SCM using whole-genome analyses and systems biology approaches. Currently,
studies of pathways from regular chromosomal imbalances and/or copy number variations (CNV) to
CIN/SCM are rare.
Genome architecture at the DNA sequence level has long been recognized as playing a key role in
formation of structural genome variations [13,14]. A large series of studies using a panel of molecular,
cytogenomic, and bioinformatic techniques have shown that structural genomic variants (chromosomal
rearrangements and CNV) frequently occur through mechanisms involving repeat sequences at the
breakpoints as well as DNA recombination-based and replication-based processes [15–19]. At the
chromosomal/subchromosomal levels, related phenomena have not been systematically addressed.
However, chromosome segregation errors have been indicated to form a wide spectrum of somatic
genome rearrangements [20]. These results promise the success of forthcoming studies of interplays
between genome behavior at chromosomal (subchromosomal) level, CIN and SCM. Therefore,
whole-genome and bioinformatic analyses of co-occurring non-mosaic and mosaic chromosomal
(subchromosomal) variations or CIN in an individual may help to uncover previously unrecognized
mechanisms for somatic genome variations at the chromosomal level.
In the present contribution, we describe an SNP (single nucleotide polymorphism)-array study of
colocalized regular/mosaic chromosome imbalances in a cohort of children with neurodevelopmental
disorders and congenital malformations. Analysis of the structural genomic variations allowed us
to propose a previously unknown pathway from regular chromosomal imbalances or CNV to SCM
(CIN). Furthermore, we have introduced a kind of theory, which might be relevant to numerous areas
of chromosome research, cytogenomics (molecular cytogenetics), and medical cytogenetics.
2. Results and Discussion
Molecular karyotyping of the Russian cohort of children with neurodevelopmental disorders and
congenital malformations [21,22], which currently includes 612 individuals, has been performed by
high resolution SNP-array using Affymetrix CytoScan platform (HD). During the analysis, we observed
concomitant regular and mosaic chromosome imbalances located at the same chromosomal locus
or encompassed similar genomic regions in 47 individuals (7.7%). These colocalized structural
chromosome abnormalities manifested as deletions or duplications with mosaic imbalances presenting
mainly larger than regular ones. Accordingly, we have suggested that the colocalizations are not
coincidental, representing, therefore, a snapshot of a possible dynamic process, which starts as a regular
chromosomal imbalance (CNV) and proceeds with the formation of mosaic imbalances by a kind of
“wreckage” at both breakpoints of the regular one. Hence, regular structural genomic variants are likely
to be the first step initiating genomic instability (GIN) at adjacent chromosomal loci (genomic regions).
The instability is likely to produce a larger rearrangement through defective DNA damage response
and/or reparation (duplication—elongation by erroneous reparation; deletion—loss of chromosome
parts). To define these colocalized chromosome abnormalities in an individual and to name the process
producing SMC and CIN/GIN from regular genomic/chromosomal changes (CNV) by a single term,
we have introduced the neologism “chromohelkosis”, which literally means “chromosome ulceration
or ulcer” (from the Greek words “chromo” designating “chromosome” and “helkosis” derived from
helkos (ἕλκoς), which means “ulceration”, “ulcer”, or “open wound”). Consequently, the process is
designated as chromohelkosis, whereas colocalized regular and mosaic chromosomal changes are
designated as chromohelkosis imbalances. We intentionally composed the word “chromohelkosis”
to mimic chromothripsis (chromosome shattering characterized by extensive rearrangements and
an oscillating pattern of DNA copy numbers), chromoanasynthesis (local chromosome shattering
associated with a random restitching of chromosomal fragments), and chromoanagenesis (complex
rearrangements at one/several chromosomal loci produced by a catastrophic event) [4–6], inasmuch as
it also seems to be a common mechanism for somatic chromosome rearrangements and CIN. Figure 1
shows three examples of chromosomal loci affected by chromohelkosis.
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Chromohelkosis imbalances have been found to affect loci of almost all chromosomes apart 
from chromosomes 6, 8, 18–21, and Y. There have been detected 26 duplications and 21 
deletions (55/45). Sizes of regular chromosome imbalances have been found to be highly 
variable from small CNV (tens to hundreds of kbp) to partial trisomies and monosomies (large 
chromosome deletions/duplications, e.g., >20 Mb). Mosaic chromosome imbalances have been 
generally more than 2 Mb, except one case (0.87 Mb). Details on the chromohelkosis imbalances 
are given in Table 1. 
Figure 1. SNP-array analysis f colocalized regular/mosaic chrom some imbalances in an individual
(chr mosomal loci suggested to be affected chro ohel sis or chromohelkosis imbal nces):
(A) regul r/mosaic deletions at q34.3q35.1; (B) regular/mosaic deletions at 7q11.23/7q11.22q21. ;
(C) regul r/mosaic duplications at 11p14.3. Da k red—regular d letions; light r i deletions;
dark bl e—regular duplication; light blue—mosaic duplication.
Chromohelkosis imbalances have been found to affect loci of almost all chromosomes apart from
chro osomes 6, 8, 18–21, and Y. There have been detected 26 duplications and 21 deletions (55/45).
Sizes of regular chromosome imbalances have been found to be highly variable from small CNV (tens to
hundreds of kbp) to partial trisomies and monosomies (large chro osome deletions/duplications,
e.g., >20 Mb). Mosaic chromosome imbalances have been generally more than 2 Mb, except one case
(0.87 Mb). Details on the chromohelkosis imbalances are given in Table 1.
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Rate (%) 2Regular Mosaic Regular Mosaic
1p36.32 1p36.33p36.32 Dup 2,793,846–3,123,524 849,466–3,586,707 0.329 2.737 20
1p36.33 1p36.33p36.32 Dup 1,134,091–1,207,463 849,466–5,278,786 0.073 4.429 25
1q21.1q21.2 1p12q21.2 Dup 146,003,044–147,398,560 118,506,747–149,965,913 1.395 31.459 20
2p25.3 2p25.3 Dup 1,611,691–1,861,548 12,770–3,007,511 0.249 2.994 25
2q22.2 q22.3 2q22.1q23.3 Del 143,410,303–145,299,945 140,410,739–150,635,360 1.889 10.224 50
2q23.1q23.3 2q22.2q24.1 Del 148,851,963–151,316,465 143,753,727–155,408,790 2.464 11.655 40
2q23.1q23.3 2q22.2q24.1 Del 149,073,384–151,886,100 144,007,224–156,393,001 2.812 12.385 45
2q24.1 2q23.3q24.2 Del 155,684,576–157,919,431 151,497,654–162,200,234 2.234 10.702 35
3p26.1 3p26.3p26.1 Dup 4,311,166–7,256,278 2,788,170–8,587,443 2.945 5.799 40
3p26.3p26.2 3p26.3p26.1 Dup 1,839,722–3,372,758 61,891–4,693,249 1.533 4.631 60
3q26.2q26.31 3q26.1q26.31 Del 170,316,791–171,650,195 165,957,466–175,300,706 1.333 9.343 30
4q34.3q35.1 4q34.3q35.1 Del 179,568,373–183,377,810 178,503,425–184,251,370 3.809 5.747 55
5q35.2q35.3 5q35.1q35.3 Del 175,029,372–177,324,736 171,538,904–180,719,789 3.395 9.180 30
7p22.1p15.2 7p22.1p15.2 Dup 4,783,314–26,275,210 4,790,968–26,522,153 21.491 21.731 80
7p22.2p21.3 7p22.3p21.3 Del 3,235,409–7,970,015 43,360–8,320,635 4.734 8.277 20
7q11.23 7q11.22q21.11 Del 72,612,042–74,610,673 68,665,592–79,305,748 1.998 10.640 40
9p24.3 9p24.3p24.2 Dup 203,861–823,845 203,861–2,593,900 0.619 2.390 30
9p24.3 9p24.3 Del 203,861–410,357 203,861–1,074,830 0.206 0.870 25
9q22.31q22.33 9q22.31q22.33 Del 96,109,697–99,973,789 95,891,880–100,145,863 3.864 4.253 70
9q34.3 9q34.13q34.3 Dup 139,053,501–139,435,356 134,317,328–141,020,389 0.381 6.703 30
9q34.3 9q34.13q34.3 Del 139,784,913–141,020,389 135,282,452–141,020,389 1.235 5.737 40
10q21.1 10q11.23q21.1 Dup 53,156,807–57,931,080 52,693,425–58,936,553 4.774 6.243 75
10q23.1q23.2 10q23.1q23.2 Del 86,412,180–88,502,670 85,638,142–89,465,109 2.090 3.826 50
11p14.3 11p14.3 Dup 23,032,300–24,850,872 19,983,179–28,380,051 1.819 8.396 25
12q24.33 12q24.33 Dup 129,804,153–130,492,863 129,577,575–133,777,902 0.688 4.200 20
12q24.33 12q24.33 Dup 129,803,493–130,485,474 130,035,491–133,777,902 0.681 3.742 20
13q12.11 13q11q12.11 Dup 21,683,950–22,155,929 19,436,287–22,422,460 0.471 2.986 20










Rate (%) 2Regular Mosaic Regular Mosaic
13q34 13q34 Del 114,085,478–115,107,733 110,963,086–115,107,733 1.022 4.144 40
14q32.2 14q32.13q32.2 Dup 99,153,952–101,024,454 95,563,168–100,095,249 1.870 4.532 20
15q11.2 15q11.2 Dup 22,770,421–23,082,328 22,770,421–25,083,880 0.311 2.313 20
15q11.2 15q11.2 Dup 22,770,421–23,288,350 22,770,421–25,318,376 0.517 2.547 25
15q11.2q13.1 15q11.2q13.1 Del 22,770,421–29,021,034 22,770,421–28,373,187 5.732 5.602 85
15q13.2q13.3 15q13.1q14 Del 30,913,573–32,914,239 28,394,840–36,544,674 2.518 8.149 25
16p11.2q11.2 16p11.2q12.1 Dup 32,038,693–46,463,769 34,448,198–51,124,520 14.425 16.676 20
16q23.1 16q22.3q23.3 Dup 77,496,014–78,916,839 73,357,720–82,335,001 1.420 8.977 30
16q24.3 16q24.2q24.3 Del 89,683,742–90,155,062 87,157,300–90,155,062 0.471 2.997 25
17p12 17p13.1p11.2 Dup 14,082,944–15,479,940 10,219,298–17,108,606 1.396 6.889 20
17p13.3 17p13.3p13.2 Del 525–1,323,904 525–4,375,742 1.323 4.375 40
17q25.3 17q25.3 Del 80,396,463–81,041,938 77,947,778–81,041,938 0.645 3.094 30
22q11.21 22q11.1q11.22 Dup 18,974,541–21,800,797 17,398,811–23,374,206 2.826 5.975 45
22q11.21 22q11.1q11.21 Dup 18,649,189–20,311,810 16,888,899–22,034,665 1.662 5.145 40
22q11.21 22q11.1q11.22 Dup 18,979,345–21,465,659 16,888,899–23,410,418 2.486 6.521 50
22q11.21 22q11.1q11.23 Dup 18,916,842–21,465,659 16,888,899–23,535,339 2.548 6.646 50
22q13.2q13.31 22q13.2q13.31 Dup 43,337,317–46,575,998 42,018,242–44,860,024 3.238 2.841 50
Xp22.31 Xp22.32p22.2 Del 6,784,550–7,495,395 4,931,788–9,634,138 0.710 4.702 25
Xp21.1 Xp21.1p11.4 Del 32,881,263–35,187,430 31,875,672–38,716,579 2.306 6.840 50
Xq28 Xq28 Dup 153,747,685–153,761,134 147,843,549–152,036,631 0.013 4.193 20
1 GRCh37/hg19. 2 mosaicism rates according to Chromosome Analysis Suite (ChAS) software (Affymetrix).
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Five chromohelkosis imbalances were recurrent, i.e., non-random variations at same genomic
regions (Figure 2). This observation allowed us to conclude that specific genome architecture is
likely to be involved in chromohelkosis as in germline and somatic variations mediating genomic
disorders [8,13–16]. Additionally, reciprocal chromohelkosis imbalances (i.e., chromohelkosis deletions
and duplications at the same chromosomal locus/genomic region) at 9p24.3, 9q34.13q34.3, and 15q11.2
have been revealed (Table 1). This observation additionally suggests that specificity of local genomic
architecture makes the loci susceptible to genomic/chromosomal rearrangements) [13,14]. However,
to provide further evidence and a molecular/cellular basis for chromohelkosis, additional analyses of
molecular karyotyping data appeared to be required.
To characterize the spectrum of chromohelkosis imbalances, we used the ratio between sizes
of regular and mosaic chromosome abnormalities. According to this parameter, cases were divided
in quartiles (Q1—the smallest ratio/the longest distance between breakpoints of regular and mosaic
imbalances; Q4—the largest ratio/the shortest distance between breakpoints of regular and mosaic
imbalances). The first quartile (Q1) comprised 27 (57%) chromohelkosis imbalances (1p (n = 2), 1q, 2p,
2q (n = 4), 3q(del), 7q, reciprocal 9p(del), and 9p(dup), reciprocal 9q(del) and 9q(dup), 11p, 12q (n = 2),
13q, 15q(dup) (n = 2), 16q(del), 16q(del), 17p(dup), 17q, Xp, Xq), whereas the remaining quartiles
(Q2–Q4) comprised 20 chromohelkosis imbalances (3p (n = 2), 4q, 5q, reciprocal 7p(del), and 7p(dup),
9q(del), 10q (n = 2), 14q, 15q(del) (n = 2), 16p, 22q (n = 5), Xp). The distribution of chromohelkosis
imbalances demonstrates a large segregation towards abnormalities with dramatically increased
sizes of mosaic ones. Q1-imbalances are, therefore, more likely to be associated with a higher rate
of local GIN both at the breakpoints and at the affected chromosomal loci. Correlations between
the ratio and patient age, chromosomal localization, or imbalance specificity (deletion/duplication)
have not been found. Thus, individual susceptibility to chromohelkosis has been proposed as the
mechanism of the occurrence and distribution in favor of Q1. As described previously, such a kind
of susceptibility may be a result of alterations to molecular and cellular pathways safeguarding
genome stability [12,23,24]. Recently, a model for pathway-based classification of genomic burden
(CNV burden) resulting in CIN/GIN and SCM was proposed [25]. Using this model and a novel
bioinformatic method for pathway-based CNV/gene prioritization [26], we evaluated CNV burden
effect on pathways required for genome stability maintenance (e.g., DNA reparation and damage
response, programmed cell death, cell cycle regulation, cancer-related pathways, etc.). Accordingly,
we retrieved ontologies of genes affected by regular CNV and chromosome imbalances in the genome
stability context and identified Ipp (index of pathway prioritization): Ipp(Q1) = 2.4 and 46 pathways;
Ipp(Q2–Q4) = 1.7 and 27 pathways (for more details, see [26]). We observed a statistically significant
difference between Q1 and Q2–Q4 in enrichment of genome stability maintenance pathways (Z-test,
p < 0.001). As a result, we concluded that non-random distribution of chromohelkosis imbalances
is likely to be caused by individual susceptibility to GIN/CIN produced by alterations to pathways
safeguarding genome stability. In other words, a kind of saturation in CNV encompassing genes
involved in these pathways may result in chromohelkosis. Moreover, a correlation between a higher
CNV burden and a measure of chromohelkosis progression appears to exist. It is highly likely that
the measure of chromohelkosis progression may be connected to repeat DNA, which is involved in
genome organization and stability [27] (discussed hereafter).
The appreciable difference between the regular and mosaic (colocalized) rearrangements is
reflected in gene content of a chromohelkosis imbalance (Supplementary Table S1). For instance, three
individuals exhibited chromohelkosis imbalances characterized by the lack of functionally annotated
genes in regions affected by regular rearrangements (chromohelkosis imbalance at 11p and twice at 2q).
In addition, numerous cases demonstrated phenotypic outcomes associated with mosaic rearrangements
but not with regular ones (e.g., rearrangements at 1p, 9q, 15q, 16q, 17p, and 22q). However, it is
noteworthy that these phenotypic manifestations are milder than those observed in recognizable
chromosomal (microdeletion or microduplication) syndromes. These observations might be used
to explain extensive variability of SCM phenotypes, as suggested previously [8,28–30]. Here, it is
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recognized that chromohelkosis may have a diagnostic relevance comparable to chromothripsis,
chromoanasynthesis, and chromoanagenesis.
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Figure 2. Spectrum of chromohelkosis imbalances classified according to chromosome arms and
recurrence at the same chromosomal locus, encompassing the same genomic region (del—deletion;
dup—duplication). Two differently colored bars show number of chromohelkosis imbalances per
chromosome. The scale of bar length is the same for all chromosomes, whereas the scale of chromosomes
is conserved.
Among others, chromohelkosis may represent a model of somatic genome variability (i.e., SMC,
GIN, and CIN). We have suggested that chromohelkosis deletions produce local instability at the
breakpoints leading to progressive loss of adjacent chromosomal regions. As a result, mosaic deletions
are larger than regular ones. This mechanism is similar to some extent to those proposed for explaining
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pathways from chromosome fragile sites to somatic chromosomal aberrations and CIN to some
extent [31,32]. Moreover, fragile sites affect replication timing producing DNA flexibility peaks
and stress inducible asynchrony at the breakage to produce GIN or CIN [31]. This process mimics
“wreckages” at the breakpoints of chromohelkosis imbalances. However, chromohelkosis is able to
lead to the loss of a larger chromosomal region due to the dynamic nature. Chromohelkosis affecting
the centromere would result in a loss of the whole chromosome (mosaic aneuploidy/monosomy).
Alterations to centromere stability (scission) have been recently shown to be a mechanism for
GIN/CIN [33]. It is also known that CIN and GIN may be mediated by pathways involving centromeric
DNA (e.g., classical/alpha satellite DNA) [3,20,33,34]. Although functional significance of centromeric
satellite DNA (constitutive heterochromatin) remains a matter of further investigation, numerous
studies indicate the involvement in granting genome/chromosome stability [35–37]. Satellite DNA
is suggested either to mediate GIN or to protect from alterations to chromosome structure [27].
Here, we propose a role of centromeric satellite DNA similar to telomeric DNA [38], which seems
to play a role in CIN caused by chromohelkosis, as well. Thus, centromeric satellite DNA protects
centromere from chromohelkosis “wreckage”. Similarly, telomeric DNA is proposed to play the
canonical role of protecting chromosomal ends from chromohelkosis “wreckage”. The failure of
centromeric satellite DNA to protect centromere from the “wreckage” would result in chromosomal
loss (aneuploidy). The failure of telomeric DNA to protect chromosomal ends from “wreckage”
would result in chromosomal rearrangements. Figure 3 schematically shows suggested mechanisms of
chromohelkosis mediated by deletions.
The elongation of duplicated regions might be mediated by fails of chromosomal DNA reparation
at the breakpoints progressively occurring during each fail. Related mechanisms for CIN have been
already described in cancers [20,23]. These duplications may also involve repeat (satellite) DNA as
a driving force for chromohelkosis progression [27]. Probably, the consequences of chromohelkosis
mediated by deletions may be used to explain a slight preponderance of duplications over deletions.
More precisely, mosaic deletion is more likely to disappear, becoming aneuploidy (chromosome loss),
whereas mosaic duplication is likely to become a larger one.
SMC and CIN are important contributors to development, homeostasis, interindividual diversity,
and disease. To be more exact, SMC and CIN are integrated parts of human prenatal development [40–42],
aging [43,44], cancer [24,45,46], interindividual/intercellular genome diversification, and disease [40,47–52].
SMC and CIN are considered a major focus of basic and diagnostic research for providing therapeutic
opportunities in disease and aging [29,52–54]. Therefore, it is hard to overestimate the role of SMC
and CIN. Our current observation hallmarks a common mechanism of somatic genome variability
produced by chromosomal imbalances and CNV. Taking into account a kind of omnipresence of
chromosomal variations and CNV [7,28,47,53], the chromohelkosis-based pathway to SMC/CIN might
underlie a cytogenomic theory, which would be relevant to numerous areas of genetics, genomics,
and chromosome research. In our opinion, such a theory resembles the elusive theory of everything
described by Stephen Hawking and Leonard Mlodinow [55], because both create a temptation to
explain almost everything in a given research area. To decrease the temptation, we used metaphoric
(ironic) designation “the cytogenomic theory of everything” for the system explaining chromohelkosis
contribution to SCM/CIN. Finally, recognizing empirical and theoretical weaknesses of our contribution,
we nevertheless insist that chromohelkosis is a process to explore for understanding structural variability
and flexibility of the genome.
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Consequently, wreckage may occur through altered DNA damage response and reparation, which 
cause progressive loss of chromosomal DNA localized at the breakpoints. According to the theory, 
(centromeric) satellite DNA protects chromosomes from propagation of chromohelkosis in the same 
way as telomeres do. However, the protection may fail to initiate two scenarios: (i) the distal 
chromosome part is wrecked and lost, when telomeres are affected; as a result, somatic chromosome 
rearrangements are formed (on the right-hand side); (ii) the proximal chromosome part is wrecked 
and, if centromeric satellite DNA fails to protect the centromere, the whole chromosome is lost (i.e., 
aneuploidy/monosomy) (on the left-hand side). This cascade of CIN/GIN processes results in 
somatic mosaicism and CIN, which are mechanisms for cancer, infertility, brain diseases, aging, and, 
probably, other morbid conditions. To depict a biological basis of chromohelkosis, we have used 
parts of figures from our previous articles distributed under the terms of the Creative Commons 
Attribution License [28,39]. 
Figure 3. Sche atic depiction of chro ohelkosis due to a deletion and suggested outco es relevant
to the cytogeno ic “theory of everything” (discussed hereafter). Chro oso al i balances or CNV
manifesting as deletions are able to cause instability at the sequence level (GIN) at the breakpoints.
Consequently, wreckage may occur through altered DNA damage response and reparation, which
cause progressive loss of chromosomal DNA localized at the breakpoints. According to the theory,
(centromeric) satellite DNA protects chromosomes from propagation of chromohelkosis in the same way
as telomeres do. However, the protection may fail to initiate two scenarios: (i) the distal chromosome
part is wrecked and lost, when telomeres are affected; as a result, somatic chromosome rearrangements
are formed (on the right-hand side); (ii) the proximal chromosome part is wrecked and, if centromeric
satellite DNA fails to protect the centromere, the whole chromosome is lost (i.e., aneuploidy/monosomy)
(on the left-hand side). This cascade of CIN/GIN processes results in somatic mosaicism and CIN, which
are mechanisms for cancer, infertility, brain diseases, aging, and, probably, other morbid conditions.
To depict a biological basis of chromohelkosis, we have used parts of figures from our previous articles
distri ted under the terms of the Creative Commons Attribution License [28,39].
3. Materials and Methods
3.1. Patients and Samples
Molecular karyotyping was performed to identify chromosomal abnormalities and CNV in
the Russian cohort of children with neurodevelopmental disorders (intellectual disability, autism,
epilepsy) and congenital anomalies (612 individuals), which has been clinically described in previous
studies [21,22]. This study was approved by the Ethics Committee of the Veltischev Research and
Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Ministry
of Health of Russian Federation, Moscow, Russia (AAAA—A18—118051590122—7 # 6, 19 June 2019).
Written informed consent was obtained from the patients’ parents.
3.2. SNP-Array
Molecular karyotyping was performed by CytoScan HD Arrays (Affymetrix, Santa Clara, CA, USA)
consisting of about 2.7 million markers. All the procedures have been repeatedly described in
detail previously [21,22,56,57]. Cytogenomic variations were visualized using the Affymetrix ChAS
(Chromosome Analysis Suite) software (CytoScan® HD Array Version 4.1.0.90/r29400). The reference
sequence was GRCh37/hg19.
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3.3. Bioinformatic Analysis
An original approach to prioritization of CNV, candidate genes, and processes using molecular
karyotyping data was carried out as described earlier [58]. The procedure is an ontology-based gene
filtering/ranking with fusion of data acquired from databases dedicated to clinical genetics, genomics,
epigenetics (gene expression), proteomics (interactome), and metabolome. Additionally, genomic data
were analyzed by obtaining the ratio between the size of regular and mosaic imbalances. Using this
ratio, imbalances were divided in quartiles. The data have been also used for pathway analysis.
Pathway Analysis
Pathway analysis was performed using CNVariome concept and data laundering protocol, which
were recently described in detail [25,26]. The enrichment by genome stability maintenance pathways
was additionally analyzed using statistical Z-test.
4. Conclusions
In summary, we observed co-occurrence of regular and mosaic imbalances (deletions/duplications)
at same chromosomal loci during molecular karyotyping. Data analysis allowed us to propose a
mechanism for SMC and CIN — chromohelkosis (chromosome ulceration/open wound). Further
exploration of this mechanism has led to suggesting a function for classical/alpha satellite DNA
(protection from the wreckage towards the centromere) and cytogenomic “theory of everything”,
a metaphorically termed system explaining chromohelkosis contribution to SCM and CIN.
Chromohelkosis is proposed to be the result of a cumulative effect of chromosomal imbalance/CNV
(or, probably, other alterations to chromosomal structure) and mutational/CNV burden, which alters
pathways of genome stability maintenance. These combinations of genomic variations would be
critical for chromohelkosis dynamics and the levels of SCM and CIN. Thus, forthcoming studies are to
uncover the spectrum of genomic variations leading to chromohelkosis to show whether this process is
restricted to specific chromosomal imbalances or CNV.
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